πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 255 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9895420

IL-1beta propeptide and IL-1Ra chimera and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9885018

High efficiency reprogramming of fibroblasts into cardiomyocytes

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9884096

Compositions and methods related to graft versus host disease and treatments thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840520

Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetyla

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9820957

Methods of treating autoimmunity

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9820951

Pulmonary disease treatment and diagnosis based on Arhgef1

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9815890

Antibodies to the C3d fragment of complement component 3

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9775876

Compositions and methods for CaMKII inhibitors and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9759731

Disease severity index for assessment of chronic liver disease and method for diagnosis of

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9701713

Compositions and methods for introduction of macromolecules into cells

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700492

Dental composites systems and methods of making the same and using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700628

Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding ther

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9701792

Composite compositions and methods of preparing and using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9695229

Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9687527

Stable glucagon formulations for the treatment of hypoglycemia

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9683025

Methods and compositions for treating cancer and inflammatory diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675678

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9650447

Complement receptor 2 (CR2) targeting groups

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9639665

Methods for diagnosis and intervention of hepatic disorders

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9631188

Human cystathionine Ξ²-synthase variants and methods of production thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9629848

Compounds that modulate autoimmunity and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9603829

HSP90 inhibitors with modified toxicity

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562088

Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562015

Methods and compositions for enhanced drug delivery to the eye and extended delivery formu

The Regents of the University of Colorado, a body Β· Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted